Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/Australia/Cagrilintide
Purchase and availability checkCagrilintide in Australia

Can you buy Cagrilintide in Australia?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Cagrilintide is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
Australia
Source records
3
Reviewed
24 July 2026
ByPeptide Local Editorial DeskUpdated 24 July 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy Cagrilintide in Australia?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. Cagrilintide is an investigational clinical program. No seller listing in Australia can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for Cagrilintide in Australia?

Resolve the exact identity of Cagrilintide through REDEFINE 1 Phase 3 study - NCT05567796 from ClinicalTrials.gov. Then search Searching the Australian Register of Therapeutic Goods from Therapeutic Goods Administration for the destination product record and Personal Importation Scheme from Therapeutic Goods Administration for the seller, establishment, or supply route in Australia. A match in one record does not replace the other two checks.

03

Does an online listing prove Cagrilintide is authorized or available in Australia?

No. A page using the name Cagrilintide, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For Australia, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

Cagrilintide clinical trials in Australia

10 study records currently list 77 locations in this country, including 10 locations individually marked Recruiting.

Registry update: 24 July 2026
Study records
10
Listed locations
77
Recruiting locations
10
Records with local recruiting sites
2
NCT07253285
Study-wide statusRecruiting

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Listed locations
3
Recruiting locations
3
Registry update
2026-07-17
NCT07564414
Study-wide statusRecruiting

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Listed locations
7
Recruiting locations
7
Registry update
2026-07-08
NCT05567796
Study-wide statusActive, not recruiting

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

Listed locations
4
Recruiting locations
0
Registry update
2026-07-17
NCT05669755
Study-wide statusActive, not recruiting

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

Listed locations
16
Recruiting locations
0
Registry update
2026-07-17
NCT06534411
Study-wide statusCompleted

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both

Listed locations
7
Recruiting locations
0
Registry update
2026-07-17
NCT06065540
Study-wide statusCompleted

A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

Listed locations
8
Recruiting locations
0
Registry update
2026-07-08
Continue the exact comparison

Related country and compound records.

Compare another tracked name in Australia, or keep Cagrilintide fixed and change the destination within Asia-Pacific. The identity, product, and seller checks remain separate.

Continue the exact comparison

Cagrilintide in Asia-Pacific

Cagrilintide across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

Cagrilintide is an investigational clinical program. No seller listing in Australia can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: REDEFINE 1 Phase 3 study - NCT05567796 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

REDEFINE 1 Phase 3 study - NCT05567796

REDEFINE 1 Phase 3 study - NCT05567796 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open REDEFINE 1 Phase 3 study - NCT05567796 ↗

Searching the Australian Register of Therapeutic Goods

Searching the Australian Register of Therapeutic Goods is maintained by Therapeutic Goods Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Searching the Australian Register of Therapeutic Goods ↗

Personal Importation Scheme

Personal Importation Scheme is maintained by Therapeutic Goods Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Personal Importation Scheme ↗
Australia / Country guide

Australia market context.

Australian search results can combine therapeutic goods on the ARTG, practitioner or pharmacy services, conditional personal-import routes, and laboratory suppliers. Those categories answer different regulatory questions and should not share one price ranking.

  • The ARTG is the public reference database for therapeutic goods that can be supplied in Australia, subject to specific exemptions and access pathways.
  • The Personal Importation Scheme is conditional, limits typical quantities, prohibits counterfeit goods, and does not amount to TGA evaluation of the imported product.
  • No Australian commercial seller is ranked until local delivery, seller category, product status, pack size, and observation date can all be demonstrated.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Search the ARTG

Check the product, sponsor, ingredient, and ARTG identifier in the TGA database; goods not included generally cannot be supplied unless an exemption or access pathway applies.

02

Verify the practitioner

Use Ahpra’s public register to match the person, profession, current registration status, and state instead of relying on a clinic biography.

03

Read import conditions

Personal importation has quantity and eligibility conditions, and the TGA states imported products have not been evaluated for safety, quality, or efficacy.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
NCT05567796: A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightClinicalTrials.gov
02
Searching the Australian Register of Therapeutic GoodsTherapeutic Goods Administration
03
Personal Importation SchemeTherapeutic Goods Administration
04
Register of practitionersAustralian Health Practitioner Regulation Agency
05
Cagrilintide study search in AustraliaClinicalTrials.gov
06
NCT07253285: A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightClinicalTrials.gov
07
NCT07564414: A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightClinicalTrials.gov
08
NCT05669755: REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood VesselsClinicalTrials.gov
09
NCT06534411: A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or BothClinicalTrials.gov
10
NCT06065540: A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorClinicalTrials.gov
Audit and handoff

Keep the exact record attached.